Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories. It also provides DXRX data solutions, including DXRX Signal, that enables potential therapy eligibility for patients within hours of a diagnostic event, enabling teams to act while treatment decisions are still pending; DXRX Physician Mapping that examines physician testing behavior using patient level data to determine testing rates, methodology, and physician to lab relationship; DXRX Lab Mapping that offers insights into labs currently testing patients diagnosed with a specific disease or biomarker; and DXRX Disease Testing Rate Tracker, which delivers biomarker testing rate reports. In addition, the company offers scientific and advisory services. It operates in North America, the United Kingdom, Europe, Asia, and internationally. The company was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.
Часто задаваемые вопросы
В каком секторе работает Diaceutics PLC (DIUXF)?
Diaceutics PLC относится к сектору Здравоохранение.
Какова текущая цена акций Diaceutics PLC (DIUXF)?
По последним данным, цена акций Diaceutics PLC составляет 2,31 $, предыдущее закрытие — 2,31 $.
Выплачивает ли Diaceutics PLC (DIUXF) дивиденды?
Нет, Diaceutics PLC не выплачивает дивиденды.
Какой бета-коэффициент (волатильность) у Diaceutics PLC (DIUXF)?
У компании Diaceutics PLC бета 0.769, что указывает на более низкую волатильность по сравнению с рынком в целом.
